Literature DB >> 32667448

Characteristics and short-term outcomes of patients with esophageal cancer with unplanned intensive care unit admissions: a retrospective cohort study.

Isabel Cristina Lima de Freitas1, Dryelen Moreira de Assis2, Cristina Prata Amendola2, Diana da Silva Russo3, Ana Paula Pierre de Moraes4, Pedro Caruso1, Antonio Paulo Nassar Júnior1.   

Abstract

OBJECTIVE: To depict the clinical presentation and outcomes of a cohort of critically ill patients with esophageal cancer.
METHODS: We carried out a multicenter retrospective study that included patients with esophageal cancer admitted to intensive care units with acute illness between September 2009 and December 2017. We collected the demographic and clinical characteristics of all included patients, as well as organ-support measures and hospital outcomes. We performed logistic regression analysis to identify independent factors associated with in-hospital mortality.
RESULTS: Of 226 patients included in the study, 131 (58.0%) patients died before hospital discharge. Squamous cell carcinoma was more frequent than adenocarcinoma, and 124 (54.9%) patients had metastatic cancer. The main reasons for admission were sepsis/septic shock and acute respiratory failure. Mechanical ventilation (OR = 6.18; 95%CI 2.86 - 13.35) and metastatic disease (OR = 7.10; 95%CI 3.35 - 15.05) were independently associated with in-hospital mortality.
CONCLUSION: In this cohort of patients with esophageal cancer admitted to intensive care units with acute illness, the in-hospital mortality rate was very high. The requirement for invasive mechanical ventilation and metastatic disease were independent prognostic factors and should be considered in discussions about the short-term outcomes of these patients.

Entities:  

Mesh:

Year:  2020        PMID: 32667448      PMCID: PMC7405734          DOI: 10.5935/0103-507x.20200041

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


INTRODUCTION

Esophageal cancer is among the most common cancers worldwide. Its 5-year survival rate, although still poor, has improved considerably in recent years.( Treatment typically involves chemotherapy, radiotherapy, and extensive surgery, all of which are associated with severe complications. Postoperative and clinical complications are associated with increased mortality in patients with esophageal cancer.( Intensive care unit (ICU) admission is common among patients with cancer. Although many studies have examined epidemiological patterns and outcomes among critically ill patients with cancer,( few studies have addressed whether specific types of cancer have different presentations and outcomes. For example, although cancer status and complications have not been associated with short-term mortality in the majority of studies of critically ill patients,( disease stage has been identified as a prognostic factor in patients with advanced lung cancer( and head and neck cancer.( More than one-quarter of all patients with esophageal cancer are admitted to the ICU during the first 2 years after diagnosis.( However, most studies of these patients have examined only postoperative outcomes following esophagectomy.( Therefore, little is known about the characteristics and outcomes of patients with esophageal cancer who have unplanned ICU admissions due to acute illness. The aims of this study were to depict the clinical presentation and outcomes of a cohort of critically ill patients with esophageal cancer and to identify the risk factors associated with in-hospital mortality in these patients.

METHODS

In this retrospective cohort study, the medical records of patients with esophageal cancer who were admitted to four ICUs in Brazil between September 2009 and December 2017 were examined. Three hospitals were dedicated cancer centers (A.C. Camargo Cancer Center, Hospital de Câncer de Barretos and Hospital de Câncer do Maranhão “Dr. Tarquinio Lopes Filho”), and one was a general hospital with a high volume of cancer patients (Hospital Moinhos de Vento). The study was approved by the ethics committees of all participating centers. Due to the observational and retrospective nature of the study, the requirement for informed patient consent was waived. We followed the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) guidelines for the reporting of observational studies.( The inclusion criteria for this study were a confirmed diagnosis of esophageal cancer, age ≥ 18 years, and admission for medical or urgent surgical reasons. Only the first ICU admission was taken into account. We excluded patients admitted for elective surgery and those transferred to other hospitals before discharge. We collected clinical data obtained at admission and data on clinical outcomes at the time of hospital discharge from patients’ electronic medical records. We collected the following data obtained at admission: age, sex, Simplified Acute Physiology Score (SAPS) 3, Sequential Organ Failure Assessment (SOFA) score, Charlson Comorbidity Index (CCI), Eastern Cooperative Oncology Group (ECOG) performance status, histological type (adenocarcinoma or squamous cell carcinoma), cancer stage, and source of and reason for admission. We also collected the following data regarding ICU and hospital stays and complications: cancer-related complications (tumor mass, bleeding, stenosis, and fistulae), delirium, organ support during ICU stay (vasopressors, mechanical ventilation, and renal replacement therapy), and lengths of ICU and hospital stays. Since points originating from tumor characteristics impact the CCI calculation, we reported a modified version of the CCI that did not take into account points from cancer characteristics. The primary outcome was in-hospital mortality.

Statistical analysis

Continuous variables are presented as medians and interquartile ranges, and categorical variables are presented as absolute numbers and percentages. Univariate analysis was performed to compare data from patients who survived and those who died during hospitalization using the Mann-Whitney or chi-squared test, as appropriate. We did not adjust for multiple comparisons in the univariate analyses. We performed logistic regression analysis to identify independent prognostic variables among seven clinical variables defined a priori (modified CCI, performance status [categorized as ECOG 0 - 1 versus ECOG 2 - 4], metastatic disease [cancer stage IV], occurrence of delirium, need for mechanical ventilation, vasopressor use, and renal replacement therapy during ICU stay). First, we evaluated collinearity by measuring the variation inflation factor (VIF). We considered a VIF > 2 as diagnostic of multicollinearity. In the case of multicollinearity, we included only the more clinically relevant variable. There were no missing values for outcomes, but there were missing values for cancer status (and, consequently, CCI) in four patients and for performance status in two. We did not impute missing values and proceeded to a complete-case analysis. The odds ratio (OR) and 95% confidence interval (95%CI) were calculated for each variable included in the model. Model calibration was assessed by the Hosmer-Lemeshow (H-L) goodness-of-fit test. A p value > 0.05 for this test was indication of good calibration. All data were analyzed with Statistical Package for Social Science (SPSS, IBM Corporation, Armonk, NY, USA) version 21.

RESULTS

This study included 226 patients with esophageal cancer admitted to the ICU between September 2009 and December 2017 (Figure 1). Table 1 shows the patients’ characteristics. Squamous cell carcinoma was more frequent than adenocarcinoma, and most patients had advanced cancer. The patients were admitted predominantly from emergency rooms and wards, and the main reasons for admission were sepsis/septic shock and acute respiratory failure. Cancer-related complications were common.
Figure 1

Study flowchart. ICU - intensive care unit.

Table 1

Characteristics of patients with esophageal cancer admitted to intensive care units due to acute illness according to vital status at hospital discharge

VariableAlive (n = 95)Dead (n = 131)p value
Age (years)61 (55 - 68)64 (56 - 72)0.01
Male81 (85.3)97 (74.0)0.04
Histological type*  0.83
    Squamous cell carcinoma70 (73.7)101 (77.1) 
    Adenocarcinoma24 (25.3)29 (22.1) 
Cancer stage  < 0.01
    II or III60 (63.1)42 (32.1) 
    IV35 (36.8)89 (67.9) 
Modified CCI2 (0 - 4)2 (0 - 3)0.52
ECOG status  0.07
    0 - 147 (49.5)49 (37.4) 
SAPS 360.5 (55 - 71.25)69.5 (61.75 - 79.25)< 0.01
SOFA score2 (1 - 5)4 (2 - 7)< 0.01
Source of admission  0.03
    Emergency room38 (40.0)48 (36.6) 
    Ward42 (44.2)76 (58.0) 
    Surgical room11 (11.6)6 (4.6) 
    Another hospital4 (4.2)1 (0.8) 
Reason for admission  0.12
    Sepsis/septic shock28 (39.4)44 (33.6) 
    Acute respiratory failure20 (21.1)46 (35.1) 
    Neurological disorders7 (7.4)7 (7.4) 
    Cardiovascular disorders12 (12.6)6 (4.6) 
    Hemorrhage5 (5.3)3 (2.3) 
Cancer-related complications   
    Stenosis9 (9.5)12 (9.2)0.94
    Fistulae17 (17.9)28 (21.4)0.52
    Tumor mass11 (11.6)34 (26.0)< 0.01
    Bleeding10 (10.5)12 (9.1)0.73
Clinical complications   
    Pneumonia33 (34.7)50 (38.2)0.64
    Atrial fibrillation13 (13.7)31 (23.7)0.06
    Delirium12 (12.6)30 (22.9)0.05
Organ support   
    Mechanical ventilation22 (23.2)75 (57.3)< 0.01
    Vasopressors32 (33.7)63 (48.1)0.02
    Renal replacement therapy4 (4.2)10 (7.6)0.29
Length of ICU stay (days)3 (2 - 6)3 (1 - 6)0.72
Length of hospital stay (days)13 (8 - 26)3 (1 - 12)< 0.01

CCI - Charlson Comorbidity Index; ECOG - Eastern Cooperative Oncology Group; SAPS - Simplified Acute Physiology Score; SOFA - Sequential Organ Failure Assessment; ICU - intensive care unit.

Two missing values. Results expressed as median (interquartile range) or n (%).

Study flowchart. ICU - intensive care unit. Characteristics of patients with esophageal cancer admitted to intensive care units due to acute illness according to vital status at hospital discharge CCI - Charlson Comorbidity Index; ECOG - Eastern Cooperative Oncology Group; SAPS - Simplified Acute Physiology Score; SOFA - Sequential Organ Failure Assessment; ICU - intensive care unit. Two missing values. Results expressed as median (interquartile range) or n (%). In total, 131 (58.0%) patients died before hospital discharge. Patients who died had higher SAPS 3 and SOFA scores at admission, higher comorbidity burdens, more metastatic disease, and increased needs for mechanical ventilation and vasopressors. There was no multicollinearity among the chosen variables (Table 2). Mechanical ventilation (OR = 6.18; 95%CI, 2.86 - 13.35) and metastatic disease (OR = 7.10; 95%CI, 3.35 - 15.05) were independently associated with in-hospital mortality (Table 3). The model was well calibrated (H-L = 7.33, p = 0.50).
Table 2

Variation inflation index of the selected variables to be included in the logistic regression model

VariableVIF
ECOG1.07
Metastastic disease1.15
Modified CCI1.26
Delirium 1.05
Mechanical ventilation1.26
Vasopressors1.26
Renal replacement therapy1.14

VIF - variation inflation index; ECOG - Eastern Cooperative Oncology Group; CCI - Charlson comorbidity index.

Table 3

Logistic regression results for risk factors independently associated with in-hospital mortality

VariableOR95%CI
ECOG 2 - 41.340.94 - 1.92
Metastatic disease7.103.35 - 15.05
Modified CCI0.880.74 - 1.05
Delirium 1.650.71 - 3.82
Vasopressor use1.340.65 - 2.76
Mechanical ventilation6.182.86 - 13.35
Renal replacement therapy1.250.32 - 4.86

OR - odds ratio; 95%CI - 95% confidence interval; ECOG - Eastern Cooperative Oncology Group; CCI - Charlson comorbidity index.

Variation inflation index of the selected variables to be included in the logistic regression model VIF - variation inflation index; ECOG - Eastern Cooperative Oncology Group; CCI - Charlson comorbidity index. Logistic regression results for risk factors independently associated with in-hospital mortality OR - odds ratio; 95%CI - 95% confidence interval; ECOG - Eastern Cooperative Oncology Group; CCI - Charlson comorbidity index.

DISCUSSION

This study showed that patients with esophageal cancer admitted to the ICU for acute illness were severely ill and had a high in-hospital mortality rate. Mechanical ventilation and metastatic disease were independently associated with in-hospital mortality. Although many studies have addressed the characteristics and outcomes of critically ill patients with solid cancers( as well as patients with esophageal cancer admitted to the ICU after elective esophagectomy,( to our knowledge, no study has focused on patients with esophageal cancer admitted with acute illness. In our cohort, such patients had a higher mortality rate than critically ill patients with solid cancers in general.( Our results are comparable to those reported for patients with advanced lung cancer( and head and neck cancer( admitted to ICUs due to acute illness. In a Dutch study of short- and long-term outcomes of patients admitted to the ICU with different types of cancer, esophageal cancer was associated with a 30-day survival rate of 93%.( However, the authors did not differentiate between patients admitted for elective and nonelective reasons. More than one-quarter of patients with esophageal cancer in this cohort were admitted to the ICU during follow-up, and many may have been selected patients with favorable therapeutic prospects.( In another study of the same cohort, upper gastrointestinal cancer was independently associated with in-hospital mortality among patients with unplanned admissions.( These results are in accordance with those of other studies suggesting that ICU admission for acute illness is associated with 50% - 70% greater mortality than is admission for elective surgery among patients with cancer.( Mechanical ventilation is a well-known risk factor for mortality in patients with cancer. The majority of the studies included in a systematic review examining the prognosis of ICU-admitted patients with solid cancer showed that the need for mechanical ventilation was associated with higher mortality rates.( In a Brazilian study, 25% of all patients with cancer admitted to ICUs required invasive mechanical ventilation, and their in-hospital mortality rate was 73%.( In our study, 44% of patients required mechanical ventilation during their ICU stay, and their in-hospital mortality rate was 76%. Therefore, as in patients with other types of cancer, the requirement for mechanical ventilation is a marker of dismal prognosis in patients with esophageal cancer. On the other hand, cancer characteristics per se are not consistently associated with worse short-term prognoses. In the systematic review conducted by Puxty et al.,( findings from a minority of studies suggested that advanced or metastatic cancer was associated with higher ICU, in-hospital, and 30-day mortality. However, metastatic disease has been independently associated with short-term mortality in patients with advanced lung cancer( and those with head and neck cancer.( It also seems to be a marker of severity in ICU-admitted patients with esophageal cancer. Our study has some important limitations. First, as it was a retrospective cohort study, so no causal inference could be drawn. Additionally, it was prone to bias due to data collection. Second, although it involved multiple centers, the study included only Brazilian hospitals with high volumes of patients with cancer. Thus, our results may not be widely generalizable. Third, we did not have access to data on decisions to limit support, which could have influenced the mortality rate of these severely ill patients. Importantly, since deceased patients had a median ICU and hospital stay of only three days, it is possible that withholding life-sustaining therapies was decided early during the ICU stay, taking into consideration some specific patient characteristics, such as metastatic disease, and, therefore, this may have created a self-fulfilling prophecy bias.

CONCLUSION

In this cohort of patients with esophageal cancer admitted to intensive care units with acute illness, the in-hospital mortality rate was very high. The requirement for invasive mechanical ventilation and metastatic disease were independent prognostic factors and should be taken into account in discussions about the short-term outcomes of patients with esophageal cancer who are admitted to intensive care units due to acute illness.
  15 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  J Clin Epidemiol       Date:  2008-04       Impact factor: 6.437

2.  Intensive care in patients with lung cancer: a multinational study.

Authors:  M Soares; A-C Toffart; J-F Timsit; G Burghi; C Irrazábal; N Pattison; E Tobar; B F C Almeida; U V A Silva; L C P Azevedo; A Rabbat; C Lamer; A Parrot; V C Souza-Dantas; F Wallet; F Blot; G Bourdin; C Piras; J Delemazure; M Durand; D Tejera; J I F Salluh; E Azoulay
Journal:  Ann Oncol       Date:  2014-06-20       Impact factor: 32.976

3.  Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study.

Authors:  Luciano C P Azevedo; Pedro Caruso; Ulysses V A Silva; André P Torelly; Eliézer Silva; Ederlon Rezende; José J Netto; Claudio Piras; Suzana M A Lobo; Marcos F Knibel; José M Teles; Ricardo A Lima; Bruno S Ferreira; Gilberto Friedman; Alvaro Rea-Neto; Felipe Dal-Pizzol; Fernando A Bozza; Jorge I F Salluh; Márcio Soares
Journal:  Chest       Date:  2014-08       Impact factor: 9.410

4.  Characteristics and Outcome of Cancer Patients Admitted to the ICU in England, Wales, and Northern Ireland and National Trends Between 1997 and 2013.

Authors:  Marlies Ostermann; Paloma Ferrando-Vivas; Carmen Gore; Sarah Power; David Harrison
Journal:  Crit Care Med       Date:  2017-10       Impact factor: 7.598

5.  Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study.

Authors:  M Rutegård; P Lagergren; I Rouvelas; R Mason; J Lagergren
Journal:  Eur J Surg Oncol       Date:  2012-04-06       Impact factor: 4.424

6.  Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study.

Authors:  Márcio Soares; Pedro Caruso; Eliézer Silva; José M M Teles; Suzana M A Lobo; Gilberto Friedman; Felipe Dal Pizzol; Patricia V C Mello; Fernando A Bozza; Ulisses V A Silva; André P Torelly; Marcos F Knibel; Ederlon Rezende; José J Netto; Claudio Piras; Aline Castro; Bruno S Ferreira; Alvaro Réa-Neto; Patrícia B Olmedo; Jorge I F Salluh
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

Review 7.  Cancer treatment and survivorship statistics, 2014.

Authors:  Carol E DeSantis; Chun Chieh Lin; Angela B Mariotto; Rebecca L Siegel; Kevin D Stein; Joan L Kramer; Rick Alteri; Anthony S Robbins; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-06-01       Impact factor: 508.702

8.  Outcomes and prognostic factors in patients with head and neck cancer and severe acute illnesses.

Authors:  Márcio Soares; Jorge I F Salluh; Luisa Toscano; Fernando L Dias
Journal:  Intensive Care Med       Date:  2007-07-10       Impact factor: 17.440

Review 9.  Survival in solid cancer patients following intensive care unit admission.

Authors:  Kathryn Puxty; Philip McLoone; Tara Quasim; John Kinsella; David Morrison
Journal:  Intensive Care Med       Date:  2014-09-16       Impact factor: 17.440

10.  Intensive care admission of cancer patients: a comparative analysis.

Authors:  Monique M E M Bos; Ilona W M Verburg; Ineke Dumaij; Jacqueline Stouthard; Johannes W R Nortier; Dick Richel; Eric P A van der Zwan; Nicolette F de Keizer; Evert de Jonge
Journal:  Cancer Med       Date:  2015-04-18       Impact factor: 4.452

View more
  1 in total

Review 1.  A Systematic Review and Meta-Analysis Evaluating Geographical Variation in Outcomes of Cancer Patients Treated in ICUs.

Authors:  Lama H Nazer; Maria A Lopez-Olivo; Anne Rain Brown; John A Cuenca; Michael Sirimaturos; Khader Habash; Nada AlQadheeb; Heather May; Victoria Milano; Amy Taylor; Joseph L Nates
Journal:  Crit Care Explor       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.